BlackRock Health Sciences Opps Instl holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.
BlackRock Health Sciences Opportunities Portfolio Institutional Shares SHSSX
- NAV / 1-Day Return 74.07 / −1.41 %
- Total Assets 6.2B
-
Adj. Expense Ratio
0.840%
- Expense Ratio 0.840%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Health
- Investment Style Large Value
- Min. Initial Investment 2M
- Status Open
- TTM Yield 0.35%
- Turnover 43%
USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 12:41 AM GMT+0
Morningstar’s Analysis SHSSX
Will SHSSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 51.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 12.29 | 726M | Healthcare |
Johnson & Johnson | 7.96 | 470M | Healthcare |
UnitedHealth Group Inc | 6.10 | 360M | Healthcare |
Merck & Co Inc | 4.94 | 292M | Healthcare |
Gilead Sciences Inc | 4.19 | 248M | Healthcare |
AbbVie Inc | 3.94 | 233M | Healthcare |
Amgen Inc | 3.37 | 199M | Healthcare |
Thermo Fisher Scientific Inc | 3.02 | 178M | Healthcare |
Vertex Pharmaceuticals Inc | 2.74 | 162M | Healthcare |
Pfizer Inc | 2.61 | 154M | Healthcare |